• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

445
81
51
50
31

COUNTRY

48
19
6
6
6

PRICE

289
302
565
1,552

PUBLISHED

66
88
310
1,552

PRODUCT TYPE

1,531
14
5
2

Central Nervous System

(1,552 Products)

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Invega SR-Drug Insights,2014

“Invega SR - Drug Insights, 2014” provides Invega SR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Lunesta-Drug Insights,2014

“Lunesta - Drug Insights, 2014” provides Lunesta marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Seroxat-Drug Insights,2014

“Seroxat - Drug Insights, 2014” provides Seroxat marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Strattera-Drug Insights,2014

“Strattera - Drug Insights, 2014” provides Strattera marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Prorenal-Drug Insights,2014

“Prorenal - Drug Insights, 2014” provides Prorenal marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Zaldiar-Drug Insights,2014

“Zaldiar - Drug Insights, 2014” provides Zaldiar marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Skelaxin-Drug Insights,2014

“Skelaxin - Drug Insights, 2014” provides Skelaxin marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Zispin-Drug Insights,2014

“Zispin - Drug Insights, 2014” provides Zispin marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

August 2015
FROM

Lamictal-Drug Insights,2014

“Lamictal XR - Drug Insights, 2014” provides Lamictal XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Trioptal-Drug Insights,2014

“Trioptal - Drug Insights, 2014” provides Trioptal marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Intuniv-Drug Insights,2014

“Intuniv XR - Drug Insights, 2014” provides Intuniv XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Diprivan EML-Drug Insights,2014

“Diprivan EML - Drug Insights, 2014” provides Diprivan EML marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US,...

August 2015
FROM

Opana ER-Drug Insights,2014

“Opana ER - Drug Insights, 2014” provides Opana ER marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Imitrex-Drug Insights,2014

“Imitrex - Drug Insights, 2014” provides Imitrex marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Dysport-Drug Insights,2014

“Dysport - Drug Insights, 2014” provides Dysport marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

August 2015
FROM

Image-Guided Neurosurgery

Image-Guided Neurosurgery provides readers with an update on the revolutionary improvements in imaging and visualization relating to neurosurgery. From the development of the pneumoencephalogram, to...

July 2015

Central Nervous System Disorders Pipeline Highlights Database - 2015

Central Nervous System Disorders Pipeline Highlights Database – 2015 Update, provides most up-to-date information on key pipeline molecules in the global Central Nervous System (CNS) disorders Drug...

July 2015
FROM

Migraine - Pipeline Review, H1 2015

Migraine - Pipeline Review, H1 2015 Summary This, ‘Migraine - Pipeline Review, H1 2015’, provides an overview of the Migraine’s therapeutic pipeline. This report provides comprehensive information...

June 2015
FROM

Cancer Pain - Pipeline Review, H1 2015

Cancer Pain - Pipeline Review, H1 2015 Summary This, ‘Cancer Pain - Pipeline Review, H1 2015’, provides an overview of the Cancer Pain’s therapeutic pipeline. This report provides comprehensive information...

June 2015
FROM

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015 Summary This, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015’, provides an overview of the Attention...

June 2015
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.